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Abstract
Although all muscle cells generate contractile forces by means of organized filament systems, isoform expression patterns
of contractile and regulatory proteins in heart are not identical compared to developing, conditioned or mature skeletal
muscles. In order to determine biochemical parameters that may reflect functional variations in the Ca2-regulatory
membrane systems of different muscle types, we performed a comparative immunoblot analysis of key membrane proteins
involved in ion homeostasis. Cardiac isoforms of the K1-dihydropyridine receptor, Ca2-ATPase and calsequestrin are also
present in skeletal muscle and are up-regulated in chronic low-frequency stimulated fast muscle. In contrast, the cardiac
RyR2 isoform of the Ca2-release channel was not found in slow muscle but was detectable in neonatal skeletal muscle. Up-
regulation of RyR2 in conditioned muscle was probably due to degeneration^regeneration processes. Fiber type-specific
differences were also detected in the abundance of auxiliary subunits of the dihydropyridine receptor, the ryanodine receptor
and the Ca2-ATPase, as well as triad markers and various Ca2-binding and ion-regulatory proteins. Hence, the variation in
innervation of different types of muscle appears to have a profound influence on the levels and pattern of isoform expression
of Ca2-regulatory membrane proteins reflecting differences in the regulation of Ca2-homeostasis. However, independent of
the muscle cell type, key Ca2-regulatory proteins exist as oligomeric complexes under native conditions. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
There exists a great diversity not only in the phys-
iological regulation of excitation, contraction, relax-
ation, energy metabolism and ion homeostasis be-
tween the main types of muscle, i.e. skeletal muscle,
cardiac muscle, smooth muscle and myoepithelial
cells, but also between sub-types of skeletal muscle
¢bers. Separate groups of skeletal muscles di¡er in
their cellular heterogeneity in ¢ber types and also in
distinct variations on the molecular level of individ-
ual muscle cells [1]. Di¡erences in levels and expres-
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sion of muscle-speci¢c isoforms re£ect distinct bio-
logical adaptations to speci¢c functional demands
[2]. Based on immunohistochemical evaluations [3]
and histochemical assays exploiting the pH stabil-
ity/lability of myo¢brillar ATPase [4], several di¡er-
ent skeletal muscle ¢ber types can be di¡erentiated.
Besides qualitative histochemistry and immunohisto-
chemistry, the more recent application of quantita-
tive micro-methods including microphotometry, mi-
crobiochemical and micromolecular biological
assays, have decisively increased our understanding
of the enormous molecular complexity of skeletal
muscle ¢bers [5]. The myosin heavy chain content
of di¡erent skeletal muscle cells correlates reasonably
well with myo¢brillar ATPase-based ¢ber typing
[1,2]. Each histochemically identi¢able skeletal
muscle ¢ber seems to exhibit a highly speci¢c expres-
sion pro¢le of myosin heavy chains. This unique cel-
lular distribution of a muscle-speci¢c protein has
been the basis of a series of studies into molecular
changes of the contractile apparatus during ¢ber type
transitions induced by the physiological model sys-
tem of chronic low-frequency stimulation of fast
muscles [6]. A gradual replacement of myosin heavy
chains follows the sequence of MHCIIb to
MHCIId(x) to MHCIIa to MHCI during fast-to-
slow transformation [7]. In contrast to the stepwise
isoform exchange of myo¢brilliar proteins, relatively
little is known about the expression of cardiac iso-
forms of Ca2-channels in chronically conditioned
skeletal muscle ¢bers.
Skeletal muscle Ca2-channels play an important
role as voltage sensors or Ca2-release channels in
excitation^contraction coupling [8,9]. We could
show previously that the expression of skeletal
muscle isoforms of the transverse-tubular voltage
sensor, the K1S-subunit of the dihydropyridine recep-
tor, and the Ca2-release channel of the junctional
sarcoplasmic reticulum, the ryanodine receptor
RyR1 isoform, are drastically reduced following
chronic low-frequency stimulation [10^12]. Down-
regulation of fast skeletal muscle isoforms might be
partially compensated by an increase in slow/cardiac
isoforms, since electro-stimulation triggers the up-
regulation of mRNA encoding for the cardiac iso-
form of the dihydropyridine receptor [13]. In contrast
to earlier assumptions, recent studies have also
shown that both diaphragm and soleus muscle ex-
press mRNA for the cardiac isoform of this Ca2-
channel at a signi¢cant level [14]. To complement
these investigations on the protein level, in this study
we have performed an analysis of the expression
patterns of the cardiac isoforms of the voltage sensor
and the Ca2-release channel, i.e. the K1C-subunit
of the dihydropyridine receptor and the RyR2 iso-
form of the ryanodine receptor. These comparative
investigations may be important for our general
understanding of the molecular events occurring
during skeletal muscle adaptations to changed inner-
vation patterns. In addition, they might point out
di¡erences on the level of protein expression that
re£ect variations in the physiological ¢ne-regulation
of Ca2-homeostasis between di¡ering muscle
types.
Excitation^contraction coupling, a unique signal
transduction event in which depolarization of the
sarcolemma leads to Ca2-release from the sarcoplas-
mic reticulum, clearly di¡ers between skeletal and
cardiac muscle, slow-twitch and fast-twitch ¢bers,
neonatal and adult muscle cells, as well as between
unconditioned and chronic low-frequency stimulated
fast muscle. In adult skeletal muscle, excitation^con-
traction coupling is thought to be mediated by direct
physical interactions between the voltage-sensing K1-
dihydropyridine receptor and the sarcoplasmic retic-
ulum Ca2-release channel complex [15]. In contrast,
in cardiac muscle ¢bers Ca2-ions enter initially the
cytosol via activated dihydropyridine receptors,
which in turn triggers a Ca2-induced Ca2-release
mechanism involving the RyR2 isoform of the rya-
nodine receptor [16]. On the molecular level, the dif-
ferential expression of sub-types of dihydropyridine
receptors re£ects the two di¡erent modes of excita-
tion^contraction coupling, the cardiac or the skeletal
muscle signal transduction mechanism [17]. In the
early stages of skeletal muscle development, a phys-
iological dependency of excitation^contraction cou-
pling from a cardiac-like external Ca2-£ux is
present, but this type of signal transduction mecha-
nism declines in its importance during later stages of
postnatal skeletal muscle development [18]. Develop-
ing muscles express a variety of cardiac/slow iso-
forms abundantly, e.g. the Ca2-ATPase isoform
SERCA2 of the sarcoplasmic reticulum, the Ca2-
binding protein sCSQ-isoform of the terminal cister-
nae and the dihydropyridine receptor K1C-subunit
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isoform of the junctional transverse tubules [18^21].
During postnatal myogenesis these Ca2-regulatory
isoforms are down-regulated and their respective
fast skeletal muscle isoforms increase in relative den-
sity [21]. In the ¢rst two weeks after birth, excita-
tion^contraction coupling is therefore thought to be
more cardiac-like, but following maturation of the
triad junctions, skeletal muscle ¢bers exhibit physical
interactions between the RyR1 isoform and the K1S-
subunit of the dihydropyridine receptor [22].
Thus, in order to directly compare the expression
patterns of key Ca2-regulatory muscle proteins and
associated membrane components, we have per-
formed an immunoblot analysis of microsomal pro-
teins derived from predominantly fast-twitch muscle,
predominantly slow-twitch muscle, heart muscle and
neonatal skeletal muscle, as well as chronic low-fre-
quency stimulated fast-twitch muscle ¢bers. To un-
equivocally identify the various isoforms of muscle
proteins, monoclonal and sequence-speci¢c polyclon-
al antibodies were employed for highly speci¢c im-
munodecoration. Our analysis included the K1S-,
K1C-, K2- and L-subunits of the transverse-tubular
dihydropyridine receptor [23], the RyR1 and RyR2
isoforms of the sarcoplasmic reticulum Ca2-release
channel [24] and their regulatory FKBP12-subunit
[25], Ca2-binding proteins such as fast and slow
calsequestrin of the terminal cisternae [26], sarcalu-
menin of the longitudinal tubules [27] and calreticu-
lin [28], the junctional triad markers of 90 [29] and
94 kDa (triadin) [30], as well as the slow and fast
Ca2-ATPase [31], phospholamban [32], the Na/
Ca2-exchanger [33] and the Na/K-ATPase [34].
Immunodecoration of the fast and slow isoforms of
the myosin heavy chain [35] was used for the internal
standardization of immunoblots.
2. Materials and methods
2.1. Materials
Peroxidase-conjugated secondary antibodies and
protease inhibitors were purchased from Boehr-
inger-Mannheim (Lewis, UK). The chemical cross-
linker dithiobis-succinimidyl-propionate, as well as
chemiluminescence substrates were obtained from
Pierce and Warriner (Chester, UK). Immobilon NC
nitrocellulose membranes were from Millipore (Bed-
ford, MA, USA). All other chemicals were of ana-
lytical grade and purchased from Sigma (Dorset,
UK).
2.2. Antibodies
The speci¢city of antibodies used in this study to
di¡erentiate between varying isoform expression pat-
terns is summarized in Table 1. For the production
of polyclonal antisera against the L-subunit of the
dihydropyridine receptor [36], a peptide representing
the last 15 residues of the carboxy-terminus of this
muscle protein was coupled to keyhole limpet hemo-
cyanin carrier protein by Research Genetics (Hun-
tington, AL, USA). Sequence-speci¢c antibodies
were raised by four monthly injections, with the
use of a standard immunization protocol [37]. Mono-
clonal antibodies IIID5 against the K1S-subunit of
the dihydropyridine receptor [12], VIIID12 against
fast calsequestrin [38] and IIG12 against triadin [30]
were a generous gift from Dr. Kevin P. Campbell
(Howard Hughes Medical Institute, University of
Iowa, Iowa City, IA, USA). Polyclonal antibodies
against slow calsequestrin [12], calreticulin [12] and
FKBP12 [21], as well as monoclonal antibodies 20A,
IIH11, IID8, XIIC4, VF1c, C2C12, 2D12 and C3-33
against the K2-subunit of the dihydropyridine recep-
tor [39], the fast SERCA1 isoform of the Ca2-ATP-
ase [10], the slow SERCA2 isoform of the Ca2-
ATPase [10], sarcalumenin/53 kDa glycoprotein
[12], the 90 kDa junctional face membrane protein
[29], the Na/Ca2-exchanger [40], phospholamban
[41] and the cardiac RyR2 isoform of the Ca2-re-
lease channel [39], respectively, were purchased from
A⁄nity Bioreagents (Golden, CO, USA). Monoclo-
nal antibody C464.6 against the K1-Na/K-ATPase
[12] and polyclonal antibodies to the RyR1 [21] and
RyR3 isoforms of the Ca2-release channel were
from Upstate Biotechnology (Lake Placid, NY,
USA). Monoclonal antibodies MY-33 and
NOQ7.5-4D against the fast and slow myosin heavy
chain [35] were obtained from Sigma (Dorset, UK)
and a polyclonal antibody against the cardiac K1C-
subunit of the dihydropyridine receptor [42] was
from TCS Biologicals (Buckingham, UK).
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2.3. Chronic low-frequency stimulation
Conditioning of the left hind limb of adult male
New Zealand white rabbits was performed in the
Animal Facility of the University of Konstanz using
chronic telestimulation through the peroneal nerve
[43]. For the analysis of e¡ects of electro-stimulation
on the isoform expression pattern of key Ca2-regu-
latory membrane proteins, the tibialis anterior
muscle was continuously stimulated at 10 Hz for
4 and 30 days. In addition, in order to determine
whether discontinuation of chronic electro-stimula-
tion results in a reversal of conditioning-induced ef-
fects, a recovery study was carried out. Following
14 days of telestimulation, conditioning of the tibialis
anterior was terminated and the muscle left unstim-
ulated for 30 days prior to analysis. Animals were
killed by cervical dislocation and the tibialis anterior
was excised, cut into longitudinal sections and quick-
frozen in liquid nitrogen. Samples were stored at
370‡C prior to further usage.
2.4. Preparation of microsomal membranes
For routine membrane preparations, New Zealand
white rabbits were obtained from the Biomedical Fa-
cility of the University College Dublin, Ireland. All
preparative steps were performed at 0^4‡C in the
presence of a protease inhibitor cocktail [36]. The
microsomal fraction was isolated by standard subcel-
lular fractionation methodology from various rabbit
muscle tissues [21]: mature soleus, tibialis anterior
and extensor digitorum longus muscles, adult heart
muscle, neonatal skeletal muscle (5 days after birth),
as well as 4 and 30 days chronic low-frequency
stimulated tibialis anterior muscle. The immunoblot
analyses shown in this study illustrate representative
results from experimental data received from mem-
brane preparations of di¡erent tissue types from four
di¡erent animals. For recovery studies, microsomes
were prepared from 14 days electro-stimulated tibia-
lis anterior with or without a 30 days unstimulated
recovery period. Membrane samples were immedi-
ately used for gel electrophoresis or chemical cross-
linking analysis or otherwise quick-frozen in liquid
nitrogen and then stored at 370‡C.
2.5. Chemical crosslinking
In order to determine potential di¡erences in pro-
Table 1
Isoform-speci¢c antibodies to muscle proteins
Muscle protein Isoform speci¢city Antibody Reference
Myosin heavy chain fast MHCf mAb MY-33 [35]
Myosin heavy chain slow MHCs mAb NOQ7.5-4D [35]
Dihydropyridine receptor K1S-DHPR mAb IIID5 [12]
Dihydropyridine receptor K1C-DHPR polyclonal [42]
Dihydropyridine receptor K2-DHPR mAb 20A [39]
Dihydropyridine receptor L-DHPR polyclonal [36]
Ca2-release channel RyR1 polyclonal [21]
Ca2-release channel RyR2 mAb C3-33 [39]
Ryanodine receptor subunit FKBP12 polyclonal [21]
Triadin fast TRI mAb IIG12 [30]
Sarcalumenin fast SAR mAb XIIC4 [12]
SR glycoprotein 53 kDa SR GP mAb XIIC4 [12]
Junctional face protein 90 kDa JFP mAb VF1c [29]
Ca2-ATPase fast SERCA1 mAb IIH11 [10]
Ca2-ATPase slow SERCA2 mAb IID8 [10]
Phospholamban PLN mAb 2D12 [41]
Calsequestrin fast CSQ mAb VIIID12 [38]
Calsequestrin slow CSQ polyclonal [12]
Calreticulin CAL polyclonal [12]
Na/Ca2-exchanger Na/Ca2-exchanger mAb C2C12 [40]
Na/K-ATPase K1- Na/K-ATPase mAb C464.6 [12]
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tein^protein interactions between cardiac and skele-
tal muscle isoforms in fast muscle, heart, neonatal
skeletal muscle and chronic low-frequency stimulated
fast muscle, chemical crossslinking experiments were
performed by an established protocol [36]. Since this
analysis could only be performed with relatively
abundant Ca2-regulatory membrane proteins for a
reliable immunodetection, oligomerization of the
RyR1 isoform of the Ca2-release channel and the
SERCA1 isoform of the Ca2-ATPase was compared
with that of their slow counterparts, the RyR2 and
the SERCA2 isoforms. Microsomal fractions were
treated at room temperature in 50 mM HEPES bu¡-
er at pH 8.0 for 30 min with 100 Wg dithiobis-succi-
nimidyl-propionate per mg protein. A crosslinking-
induced decrease in relative electrophoretic mobility
was determined in the case of skeletal muscle iso-
forms for tibialis anterior muscle, neonatal muscle
and 4 days chronic low-frequency stimulated tibialis
anterior, and in the case of cardiac isoforms for heart
muscle, neonatal muscle and 4 days chronic low-fre-
quency stimulated tibialis anterior. The crosslinking
reaction was terminated using 50 Wl of 1 M ammo-
nium acetate per ml of reaction medium. Subse-
quently, samples were solubilized with sodium do-
decyl sulfate-containing sample bu¡er under non-
reducing conditions [44] and proteins were separated
by gel electrophoresis.
2.6. Gel electrophoresis and immunoblotting
To determine the isoform expression pattern of
muscle proteins, electrophoretic separation of micro-
somes was carried out under reducing conditions by
standard sodium dodecyl sulfate^polyacrylamide gel
electrophoresis [44] using 5, 7 or 8% (w/v) gels with
20 Wg protein per lane. For the analysis of crosslink-
ing-induced changes in the relative molecular mass of
protein complexes, electrophoresis was performed
under non-reducing conditions. Employing a Bio-
Rad Mini-Protean II system (Bio-Rad Laboratories,
Hemel Hempstead, UK), gels were run for 280 or
360 Vh at constant voltage, depending on the relative
molecular mass of the proteins to be analyzed. Fol-
lowing electrophoretic separation, muscle proteins
were transferred onto Immobilion NC nitrocellulose
membranes according to Towbin et al. [45] using a
Bio-Rad Mini-Protean blotting system (Bio-Rad
Laboratories, Hemel Hempstead, UK). Blocking
and incubation of nitrocellulose sheets with primary
and peroxidase-conjugated secondary antibodies was
carried out as previously described in detail [21]. The
enhanced chemiluminescence detection method was
used to visualize immunodecorated protein bands
[46].
Fig. 1. Expression pattern of the dihydropyridine receptor in
muscle tissues. Shown are immunoblots stained with antibodies
to the K1S-subunit (a), the K1C-subunit (b), and the L-subunit
(c) of the dihydropyridine receptor (DHPR) complex. See Sec-
tion 2 and Table 1 for a detailed description of antibodies
used. Lanes 1^7 represent the microsomal fraction isolated
from mature tibialis anterior (TA), mature extensor digitorum
longus (EDL), mature soleus (SOL), adult heart (H), neonatal
skeletal muscle (NEO), as well as 4 days (4d) and 30 days (30d)
chronic low-frequency stimulated tibialis anterior muscle, re-
spectively. Proteins were separated on 5% (w/v) gels for the
analysis of K1S-DHPR and K1C-DHPR and on 7% (w/v) gels
for the analysis of L-DHPR, and then transferred onto nitrocel-
lulose. Molecular weight markers are indicated on the left and
individual proteins are marked by arrows on the right.
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3. Results
To determine di¡erences in the amount and iso-
form expression pattern of Ca2-regulatory muscle
membrane proteins, microsomal preparations iso-
lated from mature tibialis anterior, extensor digito-
rum longus and soleus muscles, adult heart muscle,
neonatal skeletal muscle and chronic electro-stimu-
lated tibialis anterior muscle were compared by im-
munoblot analysis. Muscle isoforms involved in the
regulation and stabilization of the excitation^con-
traction^relaxation cycle of muscle ¢bers, i.e. the
voltage-sensing dihydropyridine receptor (Fig. 1),
the ryanodine receptor Ca2-release channel and its
FKBP12 subunit, triadin and the 90 kDa junctional
face membrane protein (Fig. 2), the Ca2-binding
proteins calsequestrin, calreticulin and sarcalumenin
(Fig. 3) and the ion-regulatory components Ca2-
ATPase, phospholamban, Na/Ca2-exchanger and
the Na/K-ATPase (Fig. 4) were studied. The
well-established distribution pattern of the fast and
slow isoforms of the myosin heavy chain (Fig. 5) are
shown for comparative purposes. Recovery studies
with chronically electro-stimulated muscles (Fig. 6)
and chemical crosslinking analyses (Fig. 7) are pre-
sented to illustrate the plasticity of muscle ¢bers and
the importance of protein^protein interactions within
Ca2-regulatory membrane complexes, respectively.
3.1. Expression pattern of the dihydropyridine
receptor in muscle tissues
Since functional di¡erences exist between the ma-
jor cardiac and skeletal muscle K1-subunit of the di-
hydropyridine receptor, i.e. the K1S- and the K1C-iso-
forms, their expression pattern in various muscle
types was investigated. Fig. 1 shows the relative dis-
tribution of the K1S-, K1C- and L-subunit of this
transverse-tubular receptor complex. The K1S-subunit
of apparent 175 kDa was clearly found in all unstim-
ulated skeletal muscle ¢bers. Its expression was high-
est in tibialis anterior and extensor digitorum longus
muscles, of lower abundance in slow-twitching soleus
6
Fig. 2. Expression pattern of the ryanodine receptor and other
triad markers in muscle tissues. Shown are immunoblots stained
with antibodies to the RyR1 (a) and RyR2 (b) isoforms of the
sarcoplasmic reticulum Ca2-release channel, the immunophilin
FK506-binding protein of apparent 12 kDa (FKBP12) (c), tria-
din (TRI) (d) and the 90 kDa junctional face membrane protein
(90 kDa JFP) (e). See Section 2 and Table 1 for a detailed de-
scription of antibodies used. Lanes 1^7 represent the microso-
mal fraction isolated from mature tibialis anterior (TA), mature
extensor digitorum longus (EDL), mature soleus (SOL), adult
heart (H), neonatal skeletal muscle (NEO), as well as 4 days
(4d) and 30 days (30d) chronic low-frequency stimulated tibialis
anterior muscle, respectively. Proteins were separated on 5%
(w/v) gels for the analysis of RyR1 and RyR2, on 7% (w/v)
gels for the analysis of triadin and the 90 kDa junctional face
membrane protein and on 8% (w/v) gels for the analysis of
FKBP12, and then transferred onto nitrocellulose. Molecular
weight markers are indicated on the left and individual proteins
are marked by arrows on the right.
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and neonatal skeletal muscle and completely absent
in the heart (Fig. 1a). In contrast, the K1C-subunit of
the dihydropyridine receptor was present at high
concentration in heart and neonatal skeletal muscle,
at intermediate levels in slow-twitch skeletal muscle
¢bers, and at its lowest level in predominantly fast-
twitch ¢bers (Fig. 1b). Between the various muscle
types investigated, no major di¡erence in the expres-
sion was found for the K2-subunit of apparent 143
kDa (not shown). In contrast, the regulatory L-sub-
unit of approximately 54 kDa showed elevated levels
in neonatal skeletal muscle and heart as compared to
mature skeletal muscle ¢bers (Fig. 1c).
Chronic low-frequency stimulation had a dramatic
e¡ect on the level and expression pattern of the prin-
cipal subunit of the dihydropyridine receptor. In
agreement with earlier studies on stimulation-in-
duced changes in Ca2-regulatory membrane com-
plexes [10^13], the relative amount of the K1S-subunit
declined after 4 days of conditioning (Fig. 1a). How-
ever, for the ¢rst time we can show here that this
decrease in the skeletal muscle-type voltage-sensor
is compensated by an up-regulation of the cardiac-
type K1C-subunit on the protein level (Fig. 1b). In-
terestingly, the abundance of the K1C-subunit of the
dihydropyridine receptor is higher following 4 days
of stimulation as compared to 30 days of condition-
ing (Fig. 1b). Immunoblotting of the L-subunit re-
vealed a very similarly increased expression level of
this protein during the fast-to-slow transition process
as was observed for the K1C-subunit (Fig. 1d). The
K2-subunit of the dihydropyridine receptor showed
only a slight decrease in its expression level following
chronic electro-stimulation (not shown), whereby this
e¡ect was much less dramatic than that described
above for the K1S-subunit of this Ca2-channel
(Fig. 1a).
3.2. Expression pattern of the ryanodine receptor and
other triad markers in muscle tissues
Another muscle Ca2-channel involved in excita-
tion^contraction coupling is the ryanodine receptor
Ca2-release channel of apparent 565 kDa. Since
three main isoforms of the ryanodine receptor exist,
we investigated the expression of the major skeletal
muscle form and the cardiac-speci¢c protein. In anal-
Fig. 3. Expression pattern of Ca2-reservoir proteins in muscle
tissues. Shown are immunoblots stained with antibodies to the
fast isoform of calsequestrin (fCSQ) (a), the slow/cardiac iso-
form of calsequestrin (sCSQ) (b), calreticulin (CAL) (c) and
sarculumenin (SAR) and its immunologically related 53 kDa
sarcoplasmic reticulum glycoprotein (53 kDa SR GP) (d). See
Section 2 and Table 1 for a detailed description of antibodies
used. Lanes 1^7 represent the microsomal fraction isolated
from mature tibialis anterior (TA), mature extensor digitorum
longus (EDL), mature soleus (SOL), adult heart (H), neonatal
skeletal muscle (NEO), as well as 4 days (4d) and 30 days (30d)
chronic low-frequency stimulated tibialis anterior muscle, re-
spectively. Proteins were separated on 7% (w/v) gels and then
transferred onto nitrocellulose. Molecular weight markers are
indicated on the left and individual proteins are marked by ar-
rows on the right.
6
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ogy to the ¢ndings for the K1S-subunit of the dihy-
dropyridine receptor (Fig. 1a), the expression of the
RyR1 isoform of the sarcoplasmic reticulum Ca2-
release channel was highest in tibialis anterior and
extensor digitorum longus muscles, of much lower
abundance in soleus and neonatal skeletal muscle,
and completely absent in the heart (Fig. 2a). Besides
the major RyR1 band of apparent 565 kDa, lower
molecular mass bands of approximately 200 to 400
kDa were also immuno-labeled. These minor RyR
bands probably represent degradation products
and/or smaller isoforms of this triad receptor. Immu-
nodecoration of the RyR2 isoform revealed a high
amount of this Ca2-channel in heart microsomes,
low levels in neonatal skeletal muscle and none in
mature skeletal muscle (Fig. 2b). Labeling of identi-
cal nitrocellulose sheets, as used for Fig. 2a, with a
polyclonal antibody to the predominant brain RyR3
isoform, did not result in any reliable immuno-stain-
ing above background (results not shown). We could
therefore not investigate the expression pattern of
this ryanodine receptor in di¡erent types of muscle
¢bers.
On the other hand, antibodies to an auxiliary com-
ponent of the Ca2-release channel, the FKBP12
component of apparent 12 kDa, showed expression
of this sarcoplasmic reticulum protein in all muscle
tissue tested (Fig. 2c). Its highest abundance was in
cardiac muscle ¢bers (Fig. 2c). FKBP12 exists as two
isoforms, FKBP12 and FKBP12.6 [47], which bind
to the RyR1 and RyR2 isoforms, respectively. How-
ever, the polyclonal antibody used does not distin-
guish between these two di¡erent protein species,
since both isoforms are very similar in their primary
structure. Two markers of the triad junction, triadin
of 94 kDa and a novel component of slightly lower
relative molecular mass, the 90 kDa junctional face
membrane protein, were both detected in predomi-
nantly fast-twitching muscles (Fig. 2d,e). Besides the
94 kDa band, a second band of apparent 200 kDa
was recognized by monoclonal antibody IIG12
against triadin, possibly representing a dimer (Fig.
2d). Triadin exists under native conditions as a
high-molecular-mass cluster of approximately 3000
kDa [30] and tightly associated dimers might exist
6
Fig. 4. Expression pattern of ion-regulatory membrane proteins
in muscle tissues. Shown are immunoblots stained with antibod-
ies to the fast SERCA1 isoform of the sarcoplasmic reticulum
Ca2-ATPase (a), the slow/cardiac SERCA2 isoform of the sar-
coplasmic reticulum Ca2-ATPase (b), the regulatory SERCA2
subunit phospholamban (PLN) (c), the Na/Ca2-exchanger (d)
and the Na/K-ATPase (e). See Section 2 and Table 1 for a
detailed description of antibodies used. Lanes 1^7 represent the
microsomal fraction isolated from mature tibialis anterior (TA),
mature extensor digitorum longus (EDL), mature soleus (SOL),
adult heart (H), neonatal skeletal muscle (NEO), as well as
4 days (4d) and 30 days (30d) chronic low-frequency stimulated
tibialis anterior muscle, respectively. Proteins were separated on
7% (w/v) (a, b, d, e) or 8% (w/v) gels (c), and then transferred
onto nitrocellulose. Molecular weight markers are indicated on
the left and individual proteins are marked by arrows on the
right.
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even under chemically reducing conditions. Both sar-
coplasmic reticulum proteins were not present in
neonatal skeletal muscle or cardiac microsomes
(Fig. 2d,e). The antibodies used for the detection of
these two proteins are directed against skeletal
muscle isoforms. Triadin and sarcalumenin exist
also as heart isoforms [48,49], but since antibodies
to both cardiac proteins are not available to us, we
could not investigate the expression pattern of these
muscle membrane proteins.
Immunoblot analysis of chronic low-frequency
stimulated tibialis anterior muscle showed that con-
comitant with a drastic decrease in the expression of
the RyR1 isoform (Fig. 2a), the cardiac-type RyR2
Ca2-release channel is up-regulated (Fig. 2b). How-
ever, in contrast to the amount of RyR2 present in
cardiac microsomes, the immunodecoration of this
isoform is relatively weak following 4 and 30 days
of electro-stimulation. This study shows for the ¢rst
time that on the protein level the decrease in the
skeletal muscle isoform is compensated by an up-
regulation of the cardiac isoform of the sarcoplasmic
reticulum ryanodine receptor during the fast-to-slow
muscle transformation process. Chronic conditioning
of fast muscle ¢bers caused a slight up-regulation of
FKBP12 after 30 days of stimulation (Fig. 3c). Fur-
thermore, electro-stimulation had a profound e¡ect
on both triad markers of 90 kDa and 94 kDa. Both
membrane proteins were drastically down-regulated
during the transition process and the relative abun-
dance of both proteins was too low to detect these
components in muscle ¢bers stimulated for more
than 4 days (Fig. 2d,e).
3.3. Expression pattern of Ca2+-reservoir proteins in
muscle tissues
The relative abundance of the major luminal Ca2-
binding proteins of the longitudinal tubules and the
terminal cisternae were investigated. Antibodies to
calsequestrin of apparent 63 kDa, calsequestrin-like
proteins of approximately 120 kDa to 200 kDa, sar-
calumenin of apparent 160 kDa and calreticulin of
approximately 60 kDa were employed to determine
the amount and isoform expression pattern of these
sarcoplasmic reticulum components which form the
major Ca2-reservoir of muscle ¢bers. Calsequestrin
exists as a fast fCSQ-isoform and as a slow/cardiac
sCSQ-isoform. Monoclonal antibody VIIID12 la-
beled the calsequestrin monomer of 63 kDa strongly
in fast-twitch muscles and slightly less intensely in
slow and neonatal muscles (Fig. 3a). No fast isoform
was detected in heart microsomes (Fig. 3a). In ma-
ture skeletal muscle, this antibody also recognized
the so-called calsequestrin-like proteins [38], which
are absent from neonatal muscle ¢bers (Fig. 3a). In
contrast, the slow isoform of calsequestrin was found
in all muscle types, whereby the highest abundance
was detectable in heart and neonatal muscle (Fig.
3b). The broader immunodecorated bands of higher
molecular mass in cardiac and neonatal preparations
possibly represent, in analogy to the mature skeletal
muscle isoforms, slow/cardiac calsequestrin-like pro-
teins. Immunoblotting with antibodies to calreticulin,
a ubiquitous Ca2-storage protein, revealed it to be
present in high amounts in heart and neonatal
muscle, but also at lower levels in mature skeletal
Fig. 5. Expression pattern of fast and slow myosin heavy chains
in muscle tissues. Shown are immunoblots stained with antibod-
ies to the fast (MHCf ) (a) and slow (MHCs) (b) isoform of the
myosin heavy chain (MHC). See Section 2 and Table 1 for a
detailed description of antibodies used. Lanes 1^7 represent the
microsomal fraction isolated from mature tibialis anterior (TA),
mature extensor digitorum longus (EDL), mature soleus (SOL),
adult heart (H), neonatal skeletal muscle (NEO), as well as
4 days (4d) and 30 days (30d) chronic low-frequency stimulated
tibialis anterior muscle, respectively. Proteins were separated on
7% (w/v) gels, and then transferred onto nitrocellulose. Molecu-
lar weight markers are indicated on the left and individual pro-
teins are marked by arrows on the right.
BBAMEM 77857 15-5-00
G.R. Froemming et al. / Biochimica et Biophysica Acta 1466 (2000) 151^168 159
muscles (Fig. 3c). The major Ca2-binding protein
and luminal Ca2-transporter in the longitudinal tu-
bules of the sarcoplasmic reticulum, sarcalumenin,
and its immunologically related sarcoplasmic reticu-
lum glycoprotein of apparent 53 kDa, were also de-
tectable in all muscle types studied. Their expression
was highest in fast muscle and lowest in cardiac and
neonatal skeletal muscle (Fig. 3d).
During the fast-to-slow muscle transformation
process, the fast isoform of calsequestrin was shown
to be present at lower amounts in 30 days stimulated
muscle ¢bers (Fig. 3a), while the slow/cardiac iso-
form was clearly up-regulated after 4 days of condi-
tioning, with a subsequent decrease in expression at
the last time point of stimulation investigated (Fig.
3b). In contrast to unstimulated mature skeletal
muscle, potential high-molecular-mass isoforms of
slow/cardiac calsequestrin were also present in elec-
tro-stimulated samples (Fig. 3b). Chronic low-fre-
quency stimulation had only a slightly elevating ef-
fect on the expression of calreticulin in tibialis
anterior muscle (Fig. 3c). The longitudinal Ca2-
binding protein sarcalumenin, and the immunologi-
cally related sarcoplasmic reticulum glycoprotein of
apparent 53 kDa glycoprotein, were both down-regu-
lated following 30 days of stimulation (Fig. 3d).
Fig. 6. Recovery study of chronic low-frequency stimulated fast muscle. Shown are immunoblots stained with antibodies to the fast
SERCA1 isoform of the sarcoplasmic reticulum Ca2-ATPase (a), the slow/cardiac SERCA2 isoform of the sarcoplasmic reticulum
Ca2-ATPase (b), the K1S-subunit of the dihydropyridine receptor (K1S-DHPR) (c), the K2-subunit of the dihydropyridine receptor
(K2-DHPR) (d), the RyR1 isoform of the ryanodine receptor Ca2-release channel (e), the immunophilin FK506-binding protein of
apparent 12 kDa (FKBP12) (c), the fast isoform of calsequestrin (fCSQ) (g), the slow/cardiac isoform of calsequestrin (sCSQ) (h), and
sarculumenin (SAR) and its immunologically related 53 kDa sarcoplasmic reticulum glycoprotein (53 kDa SR GP) (i). See Section 2
and Table 1 for a detailed description of antibodies used. Lanes 1^3 represent the microsomal fraction isolated from unstimulated
control tibialis anterior muscle (C), 14 days chronic low-frequency stimulated tibialis anterior muscle (S) and tibialis anterior muscle
left to recover for 30 days without stimulation following 14 days of chronic conditioning (R), respectively. Individual proteins are
marked by arrows on the right.
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3.4. Expression pattern of ion-regulatory membrane
proteins in muscle tissues
Many di¡erent ion pumps and ion exchangers are
directly or indirectly involved in the regulation of
Ca2-homeostasis in muscle ¢bers. Since di¡erences
exist in the physiological organization of Ca2-up-
take mechanisms between fast muscle, slow muscle
and the heart, we investigated the amount and iso-
form expression pattern of the two major muscle
Ca2-ATPases of the sarcoplasmic reticulum, SER-
CA1 and SERCA2, as well as two important ion-
regulatory surface proteins, the Na/Ca2-exchanger
and the Na/K-ATPase. Immunolabeling of the
Fig. 7. Chemical crosslinking analysis of the ryanodine receptor and the Ca2-ATPase. Shown are immunoblots stained with antibod-
ies to the RyR1 (a) and RyR2 (b) isoforms of the ryanodine receptor Ca2-release channel, as well as the SERCA1 (c) and SERCA2
(d) isoforms of the sarcoplasmic reticulum Ca2-ATPase. See Section 2 and Table 1 for a detailed description of antibodies used.
Lanes 1^4 represent in (a) and (c) microsomes isolated from control tibialis anterior muscle (C), as well as chemically crosslinked
membranes from tibialis anterior (TA), neonatal skeletal muscle (NEO) and 4 days chronic low-frequency stimulated tibialis anterior
muscle (4d), respectively. In immunoblots (b) and (d), lanes 1^4 represent microsomes isolated from control cardiac muscle (C), as
well as chemically crosslinked heart membranes (H), neonatal skeletal muscle (NEO) and 4 days chronic low-frequency stimulated ti-
bialis anterior muscle (4d), respectively. Chemical crosslinking was performed with 100 Wg dithiobis-succinimidyl-propionate per mg
membrane protein. Molecular weight markers are indicated on the left. Monomers and their high-molecular-mass oligomers are
marked by closed and open arrows, respectively.
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SERCA1 Ca2-ATPase by monoclonal antibody
IIH11 clearly revealed the di¡erential expression of
this fast isoform between fast-twitch and slow-twitch
skeletal muscles (Fig. 4a). The opposite immunodec-
oration pattern was achieved with monoclonal anti-
body IID8 against the SERCA2 Ca2-ATPase,
which was found to be predominantly expressed in
slow-twitching soleus muscle and the heart (Fig. 4b).
Expression of phospolamban, a regulatory subunit of
the slow/cardiac Ca2-ATPase, was also almost ex-
clusively found in slow-twitch skeletal muscle and
cardiac muscle (Fig. 4c). Both Ca2-ATPase isoforms
were present at relatively comparable amounts in
neonatal skeletal muscle preparations (Fig. 4a,b).
The mature Na/Ca2-exchanger of approximately
180 kDa and its proteolytic fragment of apparent 70
kDa [40] were expressed in all muscle samples inves-
tigated with the highest amount in heart, medium
levels in slow muscle and lower amounts in neonatal
and mature fast muscles (Fig. 4d). In order to prop-
erly determine potential di¡erences in the expression
levels of this protein, equal amounts of membrane
protein from the di¡erent types of muscles had to
be loaded in individual gel lanes. In addition, a reli-
able intensity of immunolabeling had to be achieved
for fractions with a relatively low density of the Na/
Ca2-exchanger. This, however, resulted in a broad-
ening of the immunodecorated band representing the
cardiac Na/Ca2-exchanger and can be accounted
for by the high amount of this surface protein
present in heart as compared to the other muscle
¢bers investigated. Monoclonal antibody C464.6 to
the K1-subunit of the Na/K-ATPase labeled all
microsomal muscle preparations. This surface pro-
tein appears to be expressed in higher abundance in
heart as compared to skeletal muscle (Fig. 4e).
Following chronic low-frequency stimulation, a
switch in the major isoforms of the sarcoplasmic re-
ticulum Ca2-ATPase seems to occur. While the ex-
pression of the SERCA2 isoform is elevated in 30
days stimulated muscle ¢bers, the SERCA1 protein
species is clearly down-regulated. In analogy to the
increase in the SERCA2 Ca2-ATPase, its regulatory
subunit phospholamban is also up-regulated during
the fast-to-slow transition process. Interestingly, con-
ditioning of fast muscle ¢bers also caused an increase
in the Na/Ca2-exchanger (Fig. 4d) and the Na/
K-ATPase (Fig. 4e). The expression of the Na/
K-ATPase is higher in 4 days stimulated muscle
as compared to 30 days of electro-stimulation (Fig.
4e). A coordinated increase in both ion-regulatory
proteins is a very important ¢nding with respect to
understanding the physiology of compensatory
mechanisms to counteract certain stimulation-in-
duced changes in K- and Ca2-homeostasis.
3.5. Expression pattern of fast and slow myosin heavy
chains in muscle tissues
For comparative purposes and in order to evaluate
the electrophoretically transferred microsomal sam-
ples from various muscle types, immunoblotting of
myosin heavy chain isoforms was performed. These
results re£ect the distribution of well established slow
and fast markers of the contractile apparatus and
can thus be used as an internal standard for the
immunoblots of Figs. 1^4. It is well established
that chronic low-frequency stimulation induces a
stepwise isoform exchange of myo¢brilliar proteins
[6]. We recently documented the gradual replacement
of myosin heavy chains in rabbit tibialis anterior in
the following sequence: MHCIIb to MHCIId(x) to
MHCIIa to MHCI [12,50]. To establish this trans-
formation pattern in the conditioned muscle speci-
mens studied in this report and to compare it to
the myosin expression pattern in the other muscle
types investigated, we used monoclonal antibodies
MY-33 and NOQ7.5-4D to the fast and slow myosin
heavy chain, respectively. Although both antibodies
do not exhibit cross-reactivity between their particu-
lar immunological determinant, i.e. the fast versus
the slow isoform, the antibody directed against the
fast isoform does not di¡erentiate between the vari-
ous fast-twitch species of the myosin heavy chain.
As illustrated in Fig. 5, the application of both
antibodies resulted in a clear distinction between
the various muscle types. The fast isoform of the
myosin heavy chain was found in high amounts in
predominantly fast-twitching tibialis anterior and ex-
tensor digitorum longus muscles and at a very low
level in slow-twitch soleus muscles (Fig. 5a). The
opposite expression pattern was observed for the
slow myosin heavy chain, which exhibited its highest
expression in slow muscle ¢bers (Fig. 5b). Micro-
somes isolated from neonatal skeletal muscles con-
tained approximately equal amounts of fast and slow
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isoforms, while only the slow myosin heavy chain
was expressed in heart (Fig. 5a,b). Chronic electro-
stimulation changed the expression pattern of these
markers of the contractile apparatus in a predictable
way. Parallel with a down-regulation of the fast iso-
form, an up-regulation of the slow isoform was ob-
served (Fig. 5a,b). This switch in the major myosin
heavy chain isoforms established the successful trans-
formation process in the muscle specimens investi-
gated.
3.6. Recovery study of chronic low-frequency
stimulated fast muscle
Although an enormous amount of information is
available about the reciprocal changes in muscle iso-
forms in response to the initiation and cessation of
chronic electro-stimulation [6,51], relatively little is
known about the e¡ect of reversal of chronic condi-
tioning on the expression of Ca2-regulatory mem-
brane proteins. We therefore performed a recovery
study of chronic low-frequency stimulated fast
muscle. Following electro-stimulation for 14 days,
conditioning was terminated and the muscle left to
recover for 30 days prior to immunoblot analysis.
The stimulation-induced down-regulation of the
SERCA1 isoform of the sarcoplasmic reticulum
Ca2-ATPase (Fig. 6a), the K1S-subunit and the K2-
subunit of the dihydropyridine receptor (Fig. 6c,d),
the RyR1 isoform of the Ca2-release channel (Fig.
6e), the fCSQ-isoform of calsequestrin (Fig. 6g), as
well as sarcalumenin and its immunologically related
sarcoplasmic reticulum glycoprotein of apparent 53
kDa (Fig. 6i) was partially or totally reversed during
the recovery period. In analogy, the up-regulation of
the SERCA2 isoform of the sarcoplasmic reticulum
Ca2-ATPase (Fig. 6b) and the sCSQ-isoform of cal-
sequestrin (Fig. 6h) was also reversed following the
change to a non-stimulation protocol. Of the above
proteins, the reversal of the down-regulation of the
K1S-subunit of the dihydropyridine receptor resulted
in the lowest levels of recovery as compared to the
concentration of these Ca2-regulatory proteins in
normal tibialis anterior muscles. The only stimula-
tion-induced e¡ect, which was not reversed in a ma-
jor way, was the drastic up-regulation of the
FKBP12 protein (Fig. 6f). The analysis of other
Ca2-regulatory proteins during the recovery period
did not result in reliable immunodecoration for prop-
er interpretation (not shown) and was thus not fur-
ther pursued.
3.7. Chemical crosslinking of the ryanodine receptor
and the Ca2+-ATPase
The ability to form oligomeric structures under
native conditions appears to be an intrinsic property
of many Ca2-regulatory membrane proteins in
muscle [9]. In order to determine potential variations
in protein^protein interactions between di¡erent
types of muscle, we carried out a chemical crosslink-
ing analysis. Using optimized concentration ratios
between the crosslinking probe and membrane pro-
teins, as well as established conditions with respect to
temperature, pH and incubation time [52], we were
able to analyze the oligomerization of relatively
abundant microsomal proteins. On the other hand,
comparative immunoblotting of many less abundant
Ca2-regulatory proteins did not result in good
enough labeling for a proper interpretation of shifts
in relative electrophoretic mobility (not shown).
Nevertheless, we could determine oligomerization of
two important muscle membrane proteins which ex-
ist as two distinct isoforms, the ryanodine receptor
Ca2-release channel and the sarcoplasmic reticulum
Ca2-ATPase.
Fig. 7 compares crosslinking-induced complexes in
adult tibialis anterior muscle, cardiac muscle, neona-
tal skeletal muscle and 4 days chronic low-frequency
stimulated fast muscle. In adult skeletal muscle and
heart, the RyR1 and the RyR2 isoform exhibit shifts
to high-molecular-mass complexes, respectively, fol-
lowing incubation with the hydrophobic 12 Aî cross-
linker dithiobis-succinimidyl-propionate (Fig. 7a,b).
Using 100 Wg crosslinker per mg membrane protein,
almost all of the cardiac isoform shifts to a complex
of approximately 3000 kDa, while only a sub-popu-
lation of the major skeletal muscle Ca2-release
channel forms large complexes under these condi-
tions. A similar result was obtained for neonatal
skeletal muscle and electro-stimulated fast muscle,
but the abundance of both receptors was much lower
as compared to the adult or non-stimulated muscle
tissues (Fig. 7a,b). Thus, the existence of oligomeric
structures of the ryanodine receptor was established
in all muscle types investigated.
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The chemical crosslinking analysis of the SERCA1
and SERCA2 isoforms of the sarcoplasmic reticulum
Ca2-ATPase in adult tibialis anterior muscle, car-
diac muscle, neonatal skeletal muscle and 4 days
chronic low-frequency stimulated fast muscle re-
vealed that these microsomal proteins also tend to
form high-molecular-mass complexes (Fig. 7c,d).
Although the results from the immunoblot analysis
of the Ca2-pumps were less clear than those pre-
sented for the ryanodine receptor isoforms (Fig.
7a,b), they revealed crosslinker-stabilized SERCA1
and SERCA2 complexes, estimated to be tetramers
of approximately 450 kDa (Fig. 7c,d). Despite chemi-
cally reducing conditions, even non-crosslinked
Ca2-ATPase units exhibit a certain degree of oligo-
meric structures making the interpretation of these
¢ndings more di⁄cult. Overall, the crosslinking anal-
ysis of the two Ca2-pump isoforms suggests that,
independent of the developmental stage, ¢ber type
or innervation pattern, these relaxation-facilitating
membrane proteins exist under native conditions in
large aggregates.
4. Discussion
Although di¡erences in the abundance and expres-
sion pattern of many muscle-speci¢c proteins have
been documented [1], very little is known about the
expression of cardiac isoforms of Ca2-channels and
auxiliary proteins on the protein level in conditioned
muscle ¢bers. Here, we compared the expression pro-
¢le of the major Ca2-regulatory membrane proteins
involved in excitation^contraction coupling, relaxa-
tion and triad stabilization in a single study using
extensive immunoblotting. In contrast to previous
studies on the single cell level [5], the major aim of
this investigation was to determine global changes in
distinct protein species in the entire ¢ber population
of a speci¢c muscle. Since besides trans-di¡erentia-
tion also degeneration^regeneration processes con-
tribute to the fast-to-slow transition process [53,54],
our biochemical approach did not di¡erentiate be-
tween di¡erent mechanisms associated with pheno-
typic alterations but analyzed overall changes in pro-
tein isoform expression.
The dihydropyridine receptor is a multimeric re-
ceptor which consists of the main K1-subunit and
its auxiliary K2/N-, L-, and Q-subunits [23]. The K1-
subunits acts as a voltage sensor and/or a Ca2-chan-
nel, depending on the isoform present in the muscle
[17]. Since mRNA studies have demonstrated the
presence of the K1C-subunit of the dihydropyridine
receptor in soleus and diaphragm, it was suggested
that these muscle ¢ber types exhibit a degree of car-
diac-like excitation^contraction coupling [14]. In
analogy, our immunoblotting data suggest that early
functional adaptations to chronic low-frequency
stimulation may be accompanied by a switch from
skeletal muscle to neonatal/cardiac-like excitation^
contraction coupling or the coexistence of both
main signal transduction mechanisms in conditioned
¢bers. We ¢nd here that, besides a switch in fast and
slow isoforms of the myosin heavy chain, a similar
change occurs for the dihydropyridine receptor. The
K1S-isoform is drastically decreased and the K1C-iso-
form increases in abundance in chronic low-fre-
quency stimulated fast skeletal muscles. Because the
amount of the K1C-subunit of the dihydropyridine
receptor in 4 days electro-stimulated muscle and
heart is comparable, the presence of the cardiac iso-
form could be su⁄cient for a cardiac-like mode of
excitation^contraction coupling [55]. In addition, the
increase in this isoform might be also due to the
appearance of satellite cell-derived myotubes during
degeneration^regeneration processes in the early
stages of muscle transformation [53,54].
While the K1-subunit operates as the principal re-
ceptor subunit, the K2/N-, L-, and Q-subunits modu-
late the activity of the K1-subunit [56,57]. Postnatal
studies on rat myotubes showed an early increase of
L-subunits prior to the up-regulation of the K1- and
K2-subunits of the transverse-tubular receptor com-
plex [20]. This suggests that the L-subunit plays a
signi¢cant role in increasing dihydropyridine recep-
tor numbers during early stages of muscle develop-
ment. Our immunoblot analysis demonstrated that
the L-subunit is strongly up-regulated after 4 days
of stimulation but returns to lower expression levels
after 30 days. This transient increase of the L-subunit
coincided with an increase in the K1C-isoform. Hence,
the L-subunit may increase the number of K1C-sub-
units of the dihydropyridine receptor during physio-
logical adaptations in the fast-to-slow transition pro-
cess.
In mature skeletal muscle ¢bers, direct physical
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coupling between the voltage sensor of the transverse
tubules and the Ca2-release channel of the sarco-
plasmic reticulum mediates signal transduction at
the triad junction [58]. Besides electron microscopical
evidence [59], co-immuno-precipitation data [60] and
chemical crosslinking studies [36], receptor domain-
binding experiments [15] strongly support this hy-
pothesis. Relatively short stretches of primary se-
quence within the II^III loop domain of the K1S-sub-
unit of the dihydropyridine receptor [61] appear to
directly interact with a cytoplasmic region of the
junctional Ca2-release channel [62]. The family of
intracellular ryanodine receptor Ca2-release chan-
nels are expressed in mammalian tissues as three iso-
forms: RyR1, RyR2 and RyR3 [63]. Skeletal muscle
and the heart contain predominantly RyR1 and
RyR2, respectively. The RyR3 isoform has a wider
tissue distribution, although originally identi¢ed in
brain [64]. Our comparative immunoblot analysis
con¢rmed the general expression pattern of the
RyR1 and RyR2 isoforms. Previous studies localized
RyR3 in brain, diaphragm and slow-twitch skeletal
muscle [65]. However, the polyclonal antibody to
RyR3 used in this report did not recognize this re-
ceptor in the various muscle types examined. This is
most likely due to the minuscule amounts of RyR3
present in crude microsomal preparations derived
from muscle homogenates, since RyR3 exhibits a
several-fold lower abundance in mature mammalian
skeletal muscle as compared to the major RyR1 iso-
form [65].
The expression of ryanodine receptor isoforms
undergoes several changes in developing skeletal
muscle, whereby both RyR1 and RyR3 are expressed
at birth [24]. Although an earlier study described the
lack of mRNA encoding for the RyR2 isoform in
myotubes [20], our immunoblot data presented here
clearly detected this isoform in neonatal muscle
specimens 5 days after birth. Hence, RyR2 is ex-
pressed in developing skeletal muscle ¢bers, and
this ¢nding further supports the idea of a cardiac-
like mode of excitation^contraction coupling in early
neonatal muscles. Interestingly, in parallel to an in-
crease in the K1C-subunit of the dihydropyridine re-
ceptor, RyR2 is also up-regulated during stimula-
tion-induced adaptations to changed functional
demands. This coordinated up-regulation of cardiac
isoforms, in parallel with a decrease in fast skeletal
muscle receptors, indicates that during the early
stages of muscle transformation a neonatal/cardiac-
like interaction might occur between the K1-subunit
of the dihydropyridine receptor and the ryanodine
receptor complex. Besides true trans-di¡erentiation,
degeneration^regeneration mechanisms [53,54] prob-
ably also account for some of the observed receptor
isoform switching.
The physiological role of many other triad-speci¢c
membrane proteins has not yet been fully elucidated.
Two junctional sarcoplasmic reticulum elements,
skeletal muscle triadin of 94 kDa and another triad
marker of apparent 90 kDa, are possibly involved in
the regulation of overall Ca2-homeostasis and/or
the structural maintenance of triads [66,67]. Since
both proteins are drastically down-regulated during
the fast-to-slow transition process, and are absent or
present at only very low levels in neonatal muscle
and the heart, these isoforms are possibly involved
in regulating and/or stabilizing the skeletal muscle
mode of excitation^contraction coupling, only.
Therefore these two triad markers might directly fa-
cilitate receptor coupling in adult skeletal muscle. In
contrast, the immunophilin protein of apparent 12
kDa, which binds the immunosuppressant drug
FK506 with high a⁄nity, was found at increased
levels in heart and 30 days stimulated fast muscle
¢bers. Consequently, the expression of the overall
population of FKBP12 proteins does not seem to
be correlated with the expression of the RyR1 iso-
form of the junctional Ca2-release channel complex.
This ubiquitous protein must therefore be a multi-
functional component, which agrees with reports that
FKBP12 is also associated with several other pro-
teins including IP3-sensitive Ca2-channels [68].
The two major Ca2-binding proteins of the lon-
gitudinal tubules and the terminal cisternae of the
highly developed endoplasmic reticulum in skeletal
muscle are calsequestrin and sarculumenin, respec-
tively [26,27]. In parallel to a slight down-regulation
of fast calsequestrin and sarcalumenin following 30
days of electro-stimulation, the slow/cardiac sCSQ-
isoforms of calsequestrin and calreticulin were in-
creased in their relative density in microsomal prep-
arations. Although the sCSQ-isoform is a major ele-
ment of the cardiac Ca2-regulatory machinery, in
mature slow-twitch muscle of rabbits it accounts
for only 25% of the total population of CSQ clusters
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[26]. Since over-expression of cardiac/slow calseques-
trin in transgenic mice has shown that this luminal
component of the sarcoplasmic reticulum is both a
storage and regulatory protein in the cardiac muscle
Ca2-signaling cascade [69], our ¢nding would agree
with the above discussed stimulation-induced switch
to a certain degree of the cardiac type of excitation^
contraction coupling. The ubiquitous Ca2-binding
protein calreticulin is not only involved in Ca2-stor-
age, but has also been implicated in many diverse
functions such as chaperone activity, cell adhesion
and cardiac development [70]. Functional studies
have suggested that calreticulin interacts with the
SERCA2 isoform of the sarcoplasmic reticulum
Ca2-ATPase [71]. Calreticulin is drastically in-
creased in its expression following heat shock treat-
ment [72]. Hence, calreticulin may act at least parti-
ally as a chaperone during the early stages of muscle
transformation. In addition, invasion of mono-
nucleated cells in stimulated muscle [53,54] might
account at least partially for the observed up-regula-
tion in this Ca2-binding protein.
To prevent refractoriness of the Ca2-regulatory
apparatus, following the transient opening of the
Ca2-release units and subsequent triggering of ¢la-
ment sliding, Ca2-ions are quickly removed from
the cytosol by two main physiological mechanisms.
In mature skeletal muscle ¢bers, the major Ca2-up-
take into the sarcoplasmic reticulum occurs via ATP-
ase-driven Ca2-pumps of the SERCA sub-type [31].
In addition, in cardiac muscle, the surface Na/Ca2-
exchanger, indirectly driven by the energy-dependent
action of the Na/K-ATPase, also facilitates ¢ber
relaxation [33]. Our study con¢rmed the established
isoform expression pattern of these Ca2-regulatory
components. The SR Ca2-ATPase exists in adult
muscle tissues as two isoforms, SERCA1 in fast-
twitch skeletal muscle and SERCA2 in slow-twitch
muscle and the heart. Neonatal muscle is an excep-
tion, because both isoforms exhibit comparable ex-
pression levels during early postnatal development,
but at later stages the SERCA1 Ca2-ATPase clearly
increases during myogenesis [21]. The isoform ex-
pression patterns of SERCA1 and SERCA2 were
strongly a¡ected by chronic low-frequency stimula-
tion. The switching of the fast isoform to the SER-
CA2 species was previously shown to be accompa-
nied by a decrease in overall Ca2-ATPase activity
[73]. This enzyme inactivation is only partially due to
isoform transitions, but can also be attributed to a
partial inactivation of the Ca2-pump [74,75].
The up-regulation of phospholamban and the
Na/Ca2-exchanger in stimulated fast muscle is an-
other strong indication that a heart muscle-like
Ca2-regulatory apparatus is expressed during ¢ber
transitions and degeneration^regeneration processes.
Phospholamban, a phosphorylatable regulator of the
slow/cardiac Ca2-pump, is normally only expressed
in cardiac and slow-twitch muscle. Our detection of
considerable amounts of this protein in electro-
stimulated tibialis anterior aggrees with a report by
Hu et al. [76], who described a coordinated up-reg-
ulation of phospholamban and the SERCA2 isoform
in electro-stimulated canine latissimus dorsi muscle.
Since the Na/Ca2-exchanger is the major pathway
for Ca2-removal from the cytosol in cardiac muscle,
it is likely that a switch from a skeletal muscle to a
more cardiac-like mode of Ca2-sequestration occurs
following muscle conditioning. The stimulation-in-
duced increase in the Na/K-ATPase might on
the one hand provide the driving force for the up-
regulated Na/Ca2-exchanger units, and may on the
other hand counteract the loss of K-ions. Lack of
this cation appears to trigger the transient refractori-
ness observed in a large population of chronically
stimulated muscle ¢bers during the early phases of
the fast-to-slow transition process [11].
Since protein^protein interactions play an impor-
tant role in the Ca2-regulatory membrane system of
mature muscle ¢bers [9], the existence of high-molec-
ular-mass complexes was studied by chemical cross-
linking. Previous ¢ndings that triadic Ca2-channels
and sarcoplasmic reticulum Ca2-ATPases from nor-
mal and stimulated skeletal muscles form very large
complexes [9,12,36,77] were con¢rmed. As reviewed
by Martonosi [78], oligomerization of the native SR
Ca2-pump is postulated to provide protection
against proteolytic degradation and might also be
important for co-operative kinetics between individ-
ual subunits within the physiologically active enzyme
complexes. Our crosslinking analysis agrees with
electron microscopical freeze-fracture analysis which
suggests SERCA1 tetramerization in mature skeletal
muscle ¢bers [78]. Since the present study also dem-
onstrated a certain degree of oligomerization of the
slow/cardiac SERCA2 isoform in developing and
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transformed skeletal muscle, as well as cardiac tissue,
one can assume that SERCA protein^protein inter-
actions also play a role during myogenesis and in the
heart. In addition, we could show for the ¢rst time
that the RyR2 isoform of the Ca2-release channel
also forms aggregates in native membranes isolated
from heart and electro-stimulated fast muscle. There-
fore the majority of Ca2-regulatory membrane pro-
teins, independent of their tissue distribution or tran-
sition stage, seem to have a strong tendency to
oligomerize. Direct protein interactions appear to
mediate the molecular basis for signal transduction,
maintenance of receptor coupling, protein stabiliza-
tion, co-operative kinetics, and protection against
proteolytic degradation in many di¡erent kinds of
muscle cells [9].
In conclusion, our extensive immunoblot analysis
of key components of excitation^contraction cou-
pling and relaxation has clearly shown that the pat-
tern of innervation has a profound in£uence on the
abundance and isoform expression of Ca2-regula-
tory membrane proteins in muscle tissues. Speci¢c
subsets of isoforms are present in skeletal muscle
versus cardiac muscle, developing versus mature skel-
etal muscle, fast-twitch ¢bers versus slow-twitch
muscles, and unstimulated versus chronic low-fre-
quency stimulated ¢bers. The diversity in isoform
expression suggests that distinct di¡erences exist in
the ¢ne-regulation of excitation^contraction cou-
pling, the facilitation of muscle relaxation and the
overall storage of luminal Ca2-ions in the various
types of muscle cells. Importantly, since recovery
studies demonstrated that stimulation-induced e¡ects
on the amount and isoform expression pattern of
most investigated Ca2-regulatory elements are re-
versible, muscle cells appear to be extremely plastic
and are thus highly adaptable to changed functional
demands. Biochemical changes in the membrane sys-
tems responsible for the regulation of muscle Ca2-
homeostasis re£ect physiological adaptations to en-
hanced contractile activity.
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